Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers-Reference-Cited by-同舟云学术

Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers

Published:2016-08 Issue:4 Volume:30 Page:529-535
ISSN:1521-6918
Container-title:Best Practice & Research Clinical Gastroenterology
language:en
Short-container-title:Best Practice & Research Clinical Gastroenterology

Author:

Klautke G.,Müller K.

Publisher

Elsevier BV

Subject

Gastroenterology

Reference26 articles.

1. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS):long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

2. Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: a matched case-control study;Liu;Radiother Oncol,2015

3. Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicenter, randomised, phase 2 trial;Mukherjee;Lancet Oncol,2013

4. Adjuvant therapy for gallbladder cancer: an analysis of the National Cancer data base;Hoehn;J Gastrointest Surg,2015

5. Irinotecan in radiation oncology;Klautke;Onkologie,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside;Advanced Drug Delivery Reviews;2020

2. Addition of Platinum Derivatives to Fluoropyrimidine-Based Neoadjuvant Chemoradiotherapy for Stage II/III Rectal Cancer: Systematic Review and Meta-Analysis;JNCI: Journal of the National Cancer Institute;2019-05-11

3. Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience;Frontiers in Oncology;2018-11-26